[Cumulative dosage study on the effect of NAB 365 and fenoterol on the values of pulmonary function, blood pressure, pulse rate and general tolerance].
D000318:Adrenergic beta-Agonists / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D000403:Airway Resistance / Q000187:drug effects*; D001794:Blood Pressure / Q000187:drug effects*; D001993:Bronchodilator Agents / Q000008:administration & dosage / Q000009:adverse effects / Q000627:therapeutic use; D055598:Chemical Phenomena; D002621:Chemistry; D002712:Chlorides / Q000627:therapeutic use; D002986:Clinical Trials as Topic; D004305:Dose-Response Relationship, Drug; D004341:Drug Evaluation; D004361:Drug Tolerance; D006339:Heart Rate / Q000187:drug effects*; D006801:Humans; D008173:Lung Diseases, Obstructive / Q000188:drug therapy; D009921:Metaproterenol / Q000008:administration & dosage* / Q000627:therapeutic use; D010627:Phenethylamines / Q000008:administration & dosage* / Q000009:adverse effects / Q000627:therapeutic use; D010636:Phenols / Q000008:administration & dosage / Q000627:therapeutic use
D000318:Adrenergic beta-Agonists; D001993:Bronchodilator Agents; D002712:Chlorides; D010627:Phenethylamines; D010636:Phenols; D009921:Metaproterenol
Akkumulative Dosiswirkungsstudie zum Einfluss von NAB 365 und Fenoterol auf Lungenfunktionswerte, Blutdruck, Pulsfrequenz und Allgemeinverträglichkeit